Trademarkia Logo

Australia

AU$
Trademark Search
Elixirgen Therapeutics

View On IPO.GOV.AU

Elixirgen Therapeutics
Registered: Registered/protected

Last updated on 10 Jan 2023

Owner Info

Elixirgen Therapeutics, Inc.

855 N. Wolfe St. Suite 624

Baltimore, MD, 21205 UNITED STATES OF AMERICA,

Serial Number

2232616 filed on 1 Dec 2021

Correspondent

Griffith Hack

Level 15,

376-390 Collins St,

Melbourne, VIC, 3000 AUSTRALIA

Elixirgen Therapeutics

Classification Information

Class [005]
Pharmaceutical drugs, Chemical preparations for medicinal purposes, Chemical preparations for pharmaceutical purposes, Preparations of organisms for m Read More

Class [035]
Retail services in relation to pharmaceutical drugs, chemical preparations.

Class [042]
Research and development of vaccines and medicines, Testing of pharmaceuticals, Research in the field of pharmaceuticals.

Mark Details

Serial Number

2232616

Registered On

1 Dec 2021

Renewal On

1 Dec 2031

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
10th Jan 2023IP Right Registered correspondence sent
10th Jan 2023IP Right Registration Published
10th Jan 2023Status change to Registered/Protected
26th Oct 2022Application Accepted correspondence sent
26th Oct 2022IP Right has been Examined
26th Oct 2022IP Right Acceptance Published
26th Oct 2022Status change to Accepted
25th Oct 2022Examination Response Received
3rd Aug 2022Customer Amendment Made correspondence sent
3rd Aug 2022Customer Amendment Made correspondence sent